Skip to main content
. Author manuscript; available in PMC: 2024 Jul 14.
Published in final edited form as: ACS Infect Dis. 2023 Jun 30;9(7):1372–1386. doi: 10.1021/acsinfecdis.3c00125

Figure 3. Systematic analyses of mutations that decrease sensitivity to nirmatrelvir and ensitrelvir.

Figure 3.

A) Illustration of yeast selection screen B) Correlation between replicates of functional scores of all Mpro variants in the absence of drug or presence of nirmatrelvir or ensitrelvir. Stop codons are shown in red and wild-type Mpro in blue.